Discontinued — last reported Q4 '17
Accenture Non-Designated Derivatives Gain (Loss), Net decreased by 94.4% to -$24.73M in Q2 2026 compared to the prior quarter. Year-over-year, this metric grew by 44.8%, from -$44.80M to -$24.73M. Over 4 years (FY 2021 to FY 2025), Non-Designated Derivatives Gain (Loss), Net shows a downward trend with a 63.4% CAGR.
High volatility in this metric indicates significant exposure to market risks like interest rates or currency fluctuations that are not fully offset by hedge accounting.
The net gain or loss recognized on derivative financial instruments that do not qualify for or are not designated as hed...
Commonly reported in the 'Other Income/Expense' section of the income statement for companies with large treasury operations.
is_cvx_non_designated_derivatives_gain_loss_net| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$13.17M | $28.32M | -$23.48M | -$13.05M | -$31.29M | -$23.48M | -$29.69M | $7.43M | -$72.09M | -$29.69M | -$20.28M | -$26.06M | -$57.23M | -$20.28M | -$4.26M | -$12.44M | -$44.80M | -$4.26M | -$24.73M | -$12.72M | -$24.73M |
| QoQ Change | — | +315.1% | -182.9% | +44.4% | -139.8% | +25.0% | -26.5% | +125.0% | <-999% | +58.8% | +31.7% | -28.5% | -119.6% | +64.6% | +79.0% | -192.3% | -260.1% | +90.5% | -481.1% | +48.6% | -94.4% |
| YoY Change | — | — | — | — | -137.6% | -182.9% | -26.5% | +157.0% | -130.4% | -26.5% | +31.7% | -450.6% | +20.6% | +31.7% | +79.0% | +52.2% | +21.7% | +79.0% | -481.1% | -2.2% | +44.8% |
We use cookies for analytics. See our Privacy and Cookie Policy.